Back to dashboard
MedicaidPrior AuthMedium impact

Stage 4 Cancer Medications

Illinois Medicaid - HFS·IL · Oncology, Hematology·Provider Notice
Effective date
Jan 1, 2019
We identified it
Jun 20, 2026
Days to comply

Summary

Starting January 1, 2019, Illinois Medicaid and other health insurers cannot require step therapy (trying other drugs first) for FDA-approved stage 4 metastatic cancer medications. Coverage must be provided as long as the drug use follows NCCN guidelines and is supported by peer-reviewed medical literature.

Action Required

Action needed
By January 1, 2019: Billing teams should update prior authorization processes to align with Public Act 100-1057. Remove step therapy requirements for stage 4 metastatic cancer drug authorizations when treatment follows NCCN guidelines. Ensure documentation shows treatment is consistent with best practices and supported by peer-reviewed literature.